Medical School News and Research

RSS

Dana-Farber nurse-scientists receive more than $1.3 million for two research projects

Nurse-scientists from the Phyllis F. Cantor Center for Research in Nursing and Patient Care Services at Dana-Farber Cancer Institute received more than $1.3 million dollars in funding for two separate research projects.

26 May 2020

Genes associated with dementia doubles the risk of developing severe COVID-19

Having a faulty gene linked to dementia doubles the risk of developing severe COVID-19, according to a large-scale study.

26 May 2020

Understanding mechanism behind antibiotic-resistant gonorrhea sets stage for new treatments

Due to the spread of antibiotic-resistant strains of Neisseria gonorrhoeae, existing treatments for gonorrhea, the sexually transmitted infection caused by the bacterium, are no longer effective. In the absence of a vaccine, there is an urgent need to develop novel treatment options.

22 May 2020

Treatment with chloroquine or hydroxychloroquine offers no benefit for COVID-19 patients

A large observational study suggests that treatment with the antimalarial drug chloroquine or its analog hydroxychloroquine (taken with or without the antibiotics azithromycin or clarithromycin) offers no benefit for patients with COVID-19.

22 May 2020

RAAS inhibitors are safe to use in COVID-19 patients, study shows

The coronavirus disease (COVID-19) is a novel illness that has spread across the globe in just five months. Caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the viral infection binds to the angiotensin-converting enzyme 2 (ACE2) to enter and invade cells.

21 May 2020

Study finds mechanism by which fish consumption reduces cardiovascular disease risk

A study by researchers from the Universitat Rovira i Virgili and Harvard Medical School has found that consuming omega 3 primarily through fish, but also in supplements containing these fatty acids, can modulate lipoproteins, that is, the particles that transport lipids through the blood, and can reduce the risk of cardiovascular disease.

21 May 2020

Scientist has ‘invisible enemy’ in sights with microscopic portraits of coronavirus

From her laboratory in the far western reaches of Montana, Elizabeth Fischer is trying to help people see what they're up against in COVID-19.

21 May 2020

Lifesaving innovation for COVID-19 will increase the already existing racial inequalities

As is the case with most fatal diseases, coronavirus disease (COVID-19) is already taking a disproportionate toll on black Americans and other disadvantaged minorities.

20 May 2020

Study may help to improve diagnosis and treatment of allergies

Results from a study led by investigators at Massachusetts General Hospital may help to improve the diagnosis and treatment of allergies, pointing to a potential marker of these conditions and a new therapeutic strategy.

20 May 2020

Scientists develop novel flow cytometry technique to quantify protein production in T-cells

A team of scientists from Hollings Cancer Center at the Medical University of South Carolina (MUSC) has developed a novel flow cytometry technique that can, for the first-time, quantify protein production in T-cells.

20 May 2020

Dana-Farber launches clinical test of blood cancer drug in COVID-19 patients

Scientists at Dana-Farber Cancer Institute have launched a clinical test of a blood cancer drug in patients infected with the COVID-19 virus. T

20 May 2020

Mount Sinai venture to develop and scale distribution of COVID antibody test kits

Mount Sinai Health System ("Mount Sinai") and Renalytix AI today announced the formation of Kantaro Biosciences, LLC ("Kantaro"), a Mount Sinai venture, to develop and scale production and distribution of a test kit based on the Mount Sinai-developed high-performance serologic assay for SARS-CoV-2 antibodies.

20 May 2020

Report describes clinical characteristics and outcomes of children hospitalized with COVID-19

While most children infected with the novel coronavirus have mild symptoms, a subset requires hospitalization and a small number require intensive care.

20 May 2020

Loss of smell added to the UK's official list of Covid-19 symptoms

The UK has joined the US, Europe and the World Health Organisation by including loss of smell or taste as an officially recognized symptom of Covid-19 – thanks in part to an international research project involving Professor Carl Philpott at the University of East Anglia.

20 May 2020

Medical School News and Research

Dana-Farber nurse-scientists receive more than $1.3 million for two research projects

Genes associated with dementia doubles the risk of developing severe COVID-19

Understanding mechanism behind antibiotic-resistant gonorrhea sets stage for new treatments

Treatment with chloroquine or hydroxychloroquine offers no benefit for COVID-19 patients

RAAS inhibitors are safe to use in COVID-19 patients, study shows

Study finds mechanism by which fish consumption reduces cardiovascular disease risk

Scientist has ‘invisible enemy’ in sights with microscopic portraits of coronavirus

Lifesaving innovation for COVID-19 will increase the already existing racial inequalities

Study may help to improve diagnosis and treatment of allergies

Scientists develop novel flow cytometry technique to quantify protein production in T-cells

Dana-Farber launches clinical test of blood cancer drug in COVID-19 patients

Mount Sinai venture to develop and scale distribution of COVID antibody test kits

Report describes clinical characteristics and outcomes of children hospitalized with COVID-19

Loss of smell added to the UK's official list of Covid-19 symptoms

COVID-19 associated with high thrombotic risk

Gene mutation linked to MEF2C haploinsufficiency syndrome

MGH researchers identify potential molecular targets for ALD drug development

Gene variants can increase risk of schizophrenia, shows study

Researchers create more crucial reagents for use in COVID-19 tests

Mount Sinai researchers are first to use AI model to analyze COVID-19 patients

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News